Real-World Renal Outcomes with Obinutuzumab and Voclosporin in Lupus Nephritis (EULAR 2026) - May 23, 2026 - Abstract #AB1137; B.1142; "Obinutuzumab was associated with stable renal function and sustained immunological improvement, while voclosporin demonstrated rapid proteinuria reduction but was accompanied by declines in eGFR in a subset of patients, leading to treatment discontinuation. These findings highlight the importance of individualised treatment selection and close renal monitoring in routine clinical practice."
Clinical • Real-world • Real-world evidence • Cardiovascular • Glomerulonephritis • Hypertension • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Otorhinolaryngology • Pneumonia • Renal Disease • Respiratory Diseases • Systemic Lupus Erythematosus
|
|
Soon Chin Toh1; Meera Patel2; Vikram Joseph1; Maria Leandro1; Alan D. Salama2; Aine Burns2; Sally Hamour2; Ruth Pepper 1, 2; David Isenberg1
|